Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

The role of smooth muscle cells in plaque stability: Therapeutic targeting potential.

Harman JL, Jørgensen HF.

Br J Pharmacol. 2019 Jun 28. doi: 10.1111/bph.14779. [Epub ahead of print] Review.

PMID:
31254285
2.

A stromal cell niche sustains ILC2-mediated type-2 conditioning in adipose tissue.

Rana BMJ, Jou E, Barlow JL, Rodriguez-Rodriguez N, Walker JA, Knox C, Jolin HE, Hardman CS, Sivasubramaniam M, Szeto A, Cohen ES, Scott IC, Sleeman MA, Chidomere CI, Cruz Migoni S, Caamano J, Jorgensen HF, Carobbio S, Vidal-Puig A, McKenzie ANJ.

J Exp Med. 2019 Jun 27. pii: jem.20190689. doi: 10.1084/jem.20190689. [Epub ahead of print]

PMID:
31248899
3.

Vascular smooth muscle cells in atherosclerosis.

Basatemur GL, Jørgensen HF, Clarke MCH, Bennett MR, Mallat Z.

Nat Rev Cardiol. 2019 Jun 26. doi: 10.1038/s41569-019-0227-9. [Epub ahead of print] Review.

PMID:
31243391
4.

Vascular Smooth Muscle Cell Plasticity and Autophagy in Dissecting Aortic Aneurysms.

Clément M, Chappell J, Raffort J, Lareyre F, Vandestienne M, Taylor AL, Finigan A, Harrison J, Bennett MR, Bruneval P, Taleb S, Jørgensen HF, Mallat Z.

Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1149-1159. doi: 10.1161/ATVBAHA.118.311727.

5.

Publisher Correction: Disease-relevant transcriptional signatures identified in individual smooth muscle cells from healthy mouse vessels.

Dobnikar L, Taylor AL, Chappell J, Oldach P, Harman JL, Oerton E, Dzierzak E, Bennett MR, Spivakov M, Jørgensen HF.

Nat Commun. 2018 Dec 17;9(1):5401. doi: 10.1038/s41467-018-07887-3.

6.

Disease-relevant transcriptional signatures identified in individual smooth muscle cells from healthy mouse vessels.

Dobnikar L, Taylor AL, Chappell J, Oldach P, Harman JL, Oerton E, Dzierzak E, Bennett MR, Spivakov M, Jørgensen HF.

Nat Commun. 2018 Nov 1;9(1):4567. doi: 10.1038/s41467-018-06891-x. Erratum in: Nat Commun. 2018 Dec 17;9(1):5401.

7.

Jmjd2c facilitates the assembly of essential enhancer-protein complexes at the onset of embryonic stem cell differentiation.

Tomaz RA, Harman JL, Karimlou D, Weavers L, Fritsch L, Bou-Kheir T, Bell E, Del Valle Torres I, Niakan KK, Fisher C, Joshi O, Stunnenberg HG, Curry E, Ait-Si-Ali S, Jørgensen HF, Azuara V.

Development. 2017 Feb 15;144(4):567-579. doi: 10.1242/dev.142489. Epub 2017 Jan 13.

8.

Extensive Proliferation of a Subset of Differentiated, yet Plastic, Medial Vascular Smooth Muscle Cells Contributes to Neointimal Formation in Mouse Injury and Atherosclerosis Models.

Chappell J, Harman JL, Narasimhan VM, Yu H, Foote K, Simons BD, Bennett MR, Jørgensen HF.

Circ Res. 2016 Dec 9;119(12):1313-1323. Epub 2016 Sep 28.

9.

Transcriptional Mechanisms of Proneural Factors and REST in Regulating Neuronal Reprogramming of Astrocytes.

Masserdotti G, Gillotin S, Sutor B, Drechsel D, Irmler M, Jørgensen HF, Sass S, Theis FJ, Beckers J, Berninger B, Guillemot F, Götz M.

Cell Stem Cell. 2015 Jul 2;17(1):74-88. doi: 10.1016/j.stem.2015.05.014. Epub 2015 Jun 25.

10.

Embryonic stem cell-derived hemangioblasts remain epigenetically plastic and require PRC1 to prevent neural gene expression.

Mazzarella L, Jørgensen HF, Soza-Ried J, Terry AV, Pearson S, Lacaud G, Kouskoff V, Merkenschlager M, Fisher AG.

Blood. 2011 Jan 6;117(1):83-7. doi: 10.1182/blood-2010-03-273128. Epub 2010 Sep 28.

11.

Can controversies be put to REST?

Jørgensen HF, Fisher AG.

Nature. 2010 Sep 2;467(7311):E3-4; discussion E5. doi: 10.1038/nature09305.

PMID:
20811409
12.

Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators.

Landeira D, Sauer S, Poot R, Dvorkina M, Mazzarella L, Jørgensen HF, Pereira CF, Leleu M, Piccolo FM, Spivakov M, Brookes E, Pombo A, Fisher C, Skarnes WC, Snoek T, Bezstarosti K, Demmers J, Klose RJ, Casanova M, Tavares L, Brockdorff N, Merkenschlager M, Fisher AG.

Nat Cell Biol. 2010 Jun;12(6):618-24. doi: 10.1038/ncb2065. Epub 2010 May 16.

13.

LOCKing in Cellular Potential.

Jørgensen HF, Fisher AG.

Cell Stem Cell. 2009 Mar 6;4(3):192-4. doi: 10.1016/j.stem.2009.02.007.

14.

Is REST required for ESC pluripotency?

Jørgensen HF, Chen ZF, Merkenschlager M, Fisher AG.

Nature. 2009 Feb 26;457(7233):E4-5; discussion E7. doi: 10.1038/nature07783.

PMID:
19242417
15.

REST selectively represses a subset of RE1-containing neuronal genes in mouse embryonic stem cells.

Jørgensen HF, Terry A, Beretta C, Pereira CF, Leleu M, Chen ZF, Kelly C, Merkenschlager M, Fisher AG.

Development. 2009 Mar;136(5):715-21. doi: 10.1242/dev.028548.

16.

MBD2-mediated transcriptional repression of the p14ARF tumor suppressor gene in human colon cancer cells.

Martin V, Jørgensen HF, Chaubert AS, Berger J, Barr H, Shaw P, Bird A, Chaubert P.

Pathobiology. 2008;75(5):281-7. doi: 10.1159/000151708. Epub 2008 Oct 15.

17.

The impact of chromatin modifiers on the timing of locus replication in mouse embryonic stem cells.

Jørgensen HF, Azuara V, Amoils S, Spivakov M, Terry A, Nesterova T, Cobb BS, Ramsahoye B, Merkenschlager M, Fisher AG.

Genome Biol. 2007;8(8):R169.

18.

Engineering a high-affinity methyl-CpG-binding protein.

Jørgensen HF, Adie K, Chaubert P, Bird AP.

Nucleic Acids Res. 2006 Aug 7;34(13):e96.

19.

Stem cells primed for action: polycomb repressive complexes restrain the expression of lineage-specific regulators in embryonic stem cells.

Jørgensen HF, Giadrossi S, Casanova M, Endoh M, Koseki H, Brockdorff N, Fisher AG.

Cell Cycle. 2006 Jul;5(13):1411-4. Epub 2006 Jul 1.

PMID:
16855402
20.

Chromatin signatures of pluripotent cell lines.

Azuara V, Perry P, Sauer S, Spivakov M, Jørgensen HF, John RM, Gouti M, Casanova M, Warnes G, Merkenschlager M, Fisher AG.

Nat Cell Biol. 2006 May;8(5):532-8. Epub 2006 Mar 29.

PMID:
16570078
21.

Mbd1 is recruited to both methylated and nonmethylated CpGs via distinct DNA binding domains.

Jørgensen HF, Ben-Porath I, Bird AP.

Mol Cell Biol. 2004 Apr;24(8):3387-95.

22.

MeCP2 and other methyl-CpG binding proteins.

Jørgensen HF, Bird A.

Ment Retard Dev Disabil Res Rev. 2002;8(2):87-93. Review.

PMID:
12112733
23.

Regulation of elongation factor-1alpha expression by growth factors and anti-receptor blocking antibodies.

Talukder AH, Jorgensen HF, Mandal M, Mishra SK, Vadlamudi RK, Clark BF, Mendelsohn J, Kumar R.

J Biol Chem. 2001 Feb 23;276(8):5636-42. Epub 2000 Dec 4.

24.

The human elongation factor 1 A-2 gene (EEF1A2): complete sequence and characterization of gene structure and promoter activity.

Bischoff C, Kahns S, Lund A, Jørgensen HF, Praestegaard M, Clark BF, Leffers H.

Genomics. 2000 Aug 15;68(1):63-70.

PMID:
10950927
25.

Rapid identification of DNA-binding proteins by mass spectrometry.

Nordhoff E, Krogsdam AM, Jorgensen HF, Kallipolitis BH, Clark BF, Roepstorff P, Kristiansen K.

Nat Biotechnol. 1999 Sep;17(9):884-8.

PMID:
10471930
26.

Different Sp1 family members differentially affect transcription from the human elongation factor 1 A-1 gene promoter.

Nielsen SJ, Praestegaard M, Jorgensen HF, Clark BF.

Biochem J. 1998 Aug 1;333 ( Pt 3):511-7.

27.

[Prophylactic activity--instructing dental students in it?].

Nørmark S, Bille J, Høffding J, Jeppesen K, Jørgensen HF, Rosenkilde E.

Tandlaegebladet. 1975 Jun;79(10):398-401. Danish. No abstract available.

PMID:
1077976

Supplemental Content

Loading ...
Support Center